Risk factors for suboptimal drug concentration of posaconazole oral suspension in patients with hematologic malignancy.
Kim EJ, Yu KS, Na SH, Nam EY, Oh HS, Kim M, Yoon SH, Lee JO, Koh Y, Song KH, Choe PG, Cho JY, Song SH, Kim ES, Kim HB, Bang SM, Kim NJ, Oh MD, Kim I, Park WB.
Kim EJ, et al. Among authors: choe pg.
J Mycol Med. 2017 Dec;27(4):539-542. doi: 10.1016/j.mycmed.2017.08.001. Epub 2017 Sep 1.
J Mycol Med. 2017.
PMID: 28867258